RNA processing in the Malaria Parasite

Malaria kills about 400,000 children each year in sub-Saharan Africa. It is caused by the single-celled eukaryote Plasmodium, a member of the apicomplexa group of parasites which also include Toxoplasma. These parasites have an extraordinary evolutionary history, for they were once photosynthetic, and contain a remnant chloroplast, known as an apicoplast. Many commonly-used anti-malarial drugs work by inhibiting RNA transcription and protein synthesis in the apicoplast. However, there is rising drug resistance so new drugs are urgently required.
This project aims to discover how RNA processing occurs in the apicoplast. It brings together parasitology, molecular biology, proteomics and structural biology in the first step of the development of a new class of anti-malarial drugs.
Our research has shown that long, polycistronic RNA transcripts are synthesized in the apicoplast.
These primary transcripts and are rapidly cleaved to mature RNA molecules. We have identified a key proteins involved in this process, an RNA binding protein (PPR1), a member of the pentapeptide repeat protein family. We have shown that the protein is essential, and have established a conditional knock-down cell line. In addition, we have established a heterologous expression system for it, and have shown that PPR1 is functional in vitro.
We have identified a number of essential proteins that control apicoplast RNA processing, including PPR1 (Hicks, eLife, 2019) and an RNAase. We now wish to see how these proteins work together to control RNA processing.
Depending on the interests of the PhD student, the options are:
- To examine how a PPR1 knock-down affects cellular morphology and life-stage progression (This is in conjunction with collaborator Prof Ross Waller, University of Cambridge)
- To obtain a structure of PPR1
- To characterize the newly-identified RNAse, and to determine if it interacts with the PPR1 protein.
- To identify further RNA-binding proteins in the apicoplast using the OOPs...